Connor M Forbes

8PUBLICATIONS
43CO-AUTHORS
Applied theatrePredictive and prognostic markersNephrology and urologyMedical molecular engineering of nucleic acids and proteinsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 14, 2026
Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0.

|Nov 26, 2025
FGF12 Enhances Prostate Cancer Cell Survival via the YB1-lncRNA Axis.

Zechao Huang, Sonia H Y Kung, Hans Adomat

|Sep 10, 2024
Break Wave Lithotripsy for Urolithiasis: Results of the First-in-Human International Multi-Institutional Clinical Trial.

Ben H Chew, Jonathan D Harper, Roger L Sur

|Jan 03, 2024
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance.

Renjie Jin, Connor M Forbes, Nicole L Miller

|Jul 13, 2022
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5-alpha reductase inhibitor treated human benign prostate hyperplasia patients.

Renjie Jin, Connor Forbes, Nicole L Miller

|Jun 14, 2022
Decision-making and improvements in health-related quality of life in patients with kidney stones: comparing surgery versus observation using a mixed methods analysis.

Connor M Forbes, Kemberlee Bonnet, Tracy Bryant

Pageof 2

Frequent Collaborators

4 joint publications

Nicole L Miller

3 joint publications

Douglas W Strand

3 joint publications

Thomas Case

3 joint publications

Robert J Matusik